Insider Shareholders with Direct Ownership of Protagonist Therapeutics, Inc (PTGX)
This section provides a comprehensive overview of the insiders with direct ownership of Protagonist Therapeutics, Inc (PTGX). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Protagonist Therapeutics, Inc Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Canaan X L.P.
> 10% Shareholder |
0 | 336,703 | 2,116,552 $105 Million | 13 |
May 17, 2018
Reduced 1.81%
|
|
Dinesh V Ph D Patel
President and CEO |
505,481 | 379,402 | 564,260 $27.9 Million | 33 |
Mar 05, 2025
Added 4.08%
|
|
Suneel Gupta
Chief Development Officer |
346,825 | 136,709 | 267,433 $13.2 Million | 16 |
Nov 26, 2024
Added 0.17%
|
|
David Y Liu
Chief R&D Strategy Officer |
130,479 | 16,898 | 167,590 $8.29 Million | 6 |
Nov 16, 2022
Added 17.41%
|
|
Arturo Md Molina
Chief Medical Officer |
153,756 | 69,864 | 83,892 $4.15 Million | 14 |
Mar 13, 2025
Reduced 26.67%
|
|
Asif Ali
Chief Financial Officer |
138,057 | 75,236 | 62,821 $3.11 Million | 17 |
Mar 12, 2025
Reduced 28.39%
|
|
Harold E Selick
Director |
17,816 | 0 | 33,126 $1.64 Million | 3 |
Jan 02, 2025
Added 13.41%
|
|
Donald A. Kalkofen
Chief Financial Officer |
15,000 | 0 | 18,521 $915,678 | 2 |
Feb 15, 2022
Added 28.82%
|
|
Bryan Giraudo
Director |
5,130 | 0 | 15,130 $748,027 | 1 |
Jan 02, 2025
Added 25.32%
|
|
Samuel R Saks
Chief Medical Officer |
12,000 | 0 | 14,000 $692,160 | 1 |
Feb 26, 2021
Added 46.15%
|
|
William D. Waddill
Director |
54,105 | 40,975 | 13,130 $649,147 | 11 |
Mar 17, 2025
Reduced 23.35%
|
|
Sarah A O'Dowd
Director |
5,130 | 0 | 5,130 $253,627 | 1 |
Jan 02, 2025
Added 50.0%
|
|
Lewis T Williams
Director |
5,130 | 0 | 5,130 $253,627 | 1 |
Jan 02, 2025
Added 50.0%
|
|
Sarah B. Noonberg
Director |
8,400 | 8,400 | 0 $0 | 4 |
Feb 11, 2021
Reduced 100.0%
|